MedTrace Logo

Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms

NCT02580903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2020-09-16

No results posted yet for this study

Summary

This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.

All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.

All patients will be followed up for a total of five years to identify prognosis.

Conditions

  • Myeloproliferative Disorders
  • Pulmonary Hypertension

Interventions

RADIATION

Radiology

Only a small subsample will require CT and right heart catherisation

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Mette Brabrand, MD · Odense University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2018-02-28
Completion
2020-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02580903 on ClinicalTrials.gov